Lipoprotein(a) as a therapeutic target in cardiovascular disease.

Lipoprotein(a) as a therapeutic target in cardiovascular disease.

Item
http://www.wikidata.org/entity/Q38213476
PCSK9 inhibitors - mechanisms of actionLipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black Individuals: The Multi-Ethnic Study of Atherosclerosis.Emerging PCSK9 inhibitors for treating dyslipidaemia: buttressing the gaps in coronary prevention.Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.Evolocumab in the treatment of dyslipidemia: pre-clinical and clinical pharmacology.Lipoprotein(a) and Arterial Stiffness Parameters.PCSK9 in context: A contemporary review of an important biological target for the prevention and treatment of atherosclerotic cardiovascular disease.Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9.Lipoprotein (a) as a Predictor of Early Stroke Recurrence in Acute Ischemic Stroke.
P2860

Lipoprotein(a) as a therapeutic target in cardiovascular disease.

Item
http://www.wikidata.org/entity/Q38213476
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Lipoprotein(a) as a therapeutic target in cardiovascular disease.
@en
type
label
Lipoprotein(a) as a therapeutic target in cardiovascular disease.
@en
prefLabel
Lipoprotein(a) as a therapeutic target in cardiovascular disease.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Lipoprotein(a) as a therapeutic target in cardiovascular disease.
@en
P2093
P2860
P304
P31
P356
10.1517/14728222.2014.920326
P407
P433
P478
P50
P577
P698
P921